Skip to content
← The Index board

Promising · 6.7/10

TUDCA (Tauroursodeoxycholic Acid)

Evidence C · mixed evidence ▲ 31.3% momentum 🥇 First scout open
6.7/ 10

TUDCA is a taurine-conjugated bile acid with a narrow but defensible liver, bile-flow, and metabolic role; Kars 2010 reported roughly 30% better hepatic and skeletal-muscle insulin sensitivity after 4 weeks in obese T2D. The ALS combination-drug story weakened after Amylyx PHOENIX failed in 2024. Read the full breakdown →

The prediction game

Where does TUDCA (Tauroursodeoxycholic Acid) go in 12 months?

Lock a call and say how sure you are. Right and confident earns the most; a leaderboard spot is the prize. No money, no stakes.

The Crowd’s Call

Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.

Your 12-month call on TUDCA (Tauroursodeoxycholic Acid)

New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.

Be the first scout on record for TUDCA (Tauroursodeoxycholic Acid). Permanent credit on this page, plus points when your call resolves.

One call per intervention. It locks the moment you submit (no edits, no cancels) and resolves in 12 months. See the scout leaderboard →

Weigh In

Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.

Tried it in real life?

Which ring does it deserve?

Same as above — one verification covers all your entries here.

Ring Promising Momentum 31.3% Updated Jul 20, 2026 How the Index ranks →

Verdict by Nick Urban, host of the High Performance Longevity podcast.

For education only, not medical advice. Supplements, peptides, and protocols can interact with medications and conditions. Talk to a qualified clinician before starting anything here.